These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 23181129)
1. A genetic association analysis of polymorphisms, rs2282695 and rs12373539, in the FOSB gene and papillary thyroid cancer. Han SA; Song JY; Min SY; Park WS; Kim MJ; Chung JH; Kwon KH Exp Ther Med; 2012 Sep; 4(3):519-523. PubMed ID: 23181129 [TBL] [Abstract][Full Text] [Related]
2. Associations between promoter polymorphism -106A/G of interleukin-11 receptor alpha and papillary thyroid cancer in Korean population. Eun YG; Shin IH; Kim MJ; Chung JH; Song JY; Kwon KH Surgery; 2012 Feb; 151(2):323-9. PubMed ID: 21982075 [TBL] [Abstract][Full Text] [Related]
3. Association Study of FOS-Like Antigen-2 Promoter Polymorphisms With Papillary Thyroid Cancer in Korean Population. Kim SW; Kim CD; Chung JH; Kwon KH Clin Exp Otorhinolaryngol; 2014 Mar; 7(1):42-6. PubMed ID: 24587880 [TBL] [Abstract][Full Text] [Related]
4. Association study of chemokine (C-C motif) ligand 5 gene polymorphism and papillary thyroid cancer. Kwon KH; Lee YC; Chung JH; Eun YG J Invest Surg; 2013 Dec; 26(6):319-24. PubMed ID: 23957698 [TBL] [Abstract][Full Text] [Related]
6. Association of the oncostatin m receptor gene polymorphisms with papillary thyroid cancer in the korean population. Hong IK; Eun YG; Chung DH; Kwon KH; Kim DY Clin Exp Otorhinolaryngol; 2011 Dec; 4(4):193-8. PubMed ID: 22232715 [TBL] [Abstract][Full Text] [Related]
7. Association between a promoter polymorphism (rs2192752, -1028A/C) of interleukin 1 receptor, type I (IL1R1) and location of papillary thyroid carcinoma in a Korean population. Park SW; Kim MK; Kwon KH; Kim J Int J Immunogenet; 2012 Dec; 39(6):501-7. PubMed ID: 22594576 [TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in bone morphogenetic protein 3 and the risk of papillary thyroid cancer. Kim YO; Hong IK; Eun YG; Nah SS; Lee S; Heo SH; Kim HK; Song HY; Kim HJ Oncol Lett; 2013 Jan; 5(1):336-340. PubMed ID: 23255945 [TBL] [Abstract][Full Text] [Related]
9. PDGFRA promoter polymorphisms are associated with the risk of papillary thyroid cancer. Kim MJ; Kim SK; Park HJ; Chung DH; Park HK; Lee JS; Kwon KH; Chung JH Mol Med Rep; 2012 May; 5(5):1267-70. PubMed ID: 22327316 [TBL] [Abstract][Full Text] [Related]
10. A missense polymorphism (rs11895564, Ala380Thr) of integrin alpha 6 is associated with the development and progression of papillary thyroid carcinoma in Korean population. Kim SK; Kim DK; Oh IH; Song JY; Kwon KH; Choe BK; Kim YH J Korean Surg Soc; 2011 Nov; 81(5):308-15. PubMed ID: 22148122 [TBL] [Abstract][Full Text] [Related]
11. Association between collagen type XI α1 gene polymorphisms and papillary thyroid cancer in a Korean population. Park HJ; Choe BK; Kim SK; Park HK; Kim JW; Chung JH; Hong IK; Chung DH; Kwon KH Exp Ther Med; 2011 Nov; 2(6):1111-1116. PubMed ID: 22977629 [TBL] [Abstract][Full Text] [Related]
12. Single nucleotide polymorphisms of the Fas gene are associated with papillary thyroid cancer. Eun YG; Lee YC; Kim SK; Chung JH; Kwon KH; Park IS Auris Nasus Larynx; 2015 Aug; 42(4):326-31. PubMed ID: 25824544 [TBL] [Abstract][Full Text] [Related]
13. Association study of integrins beta 1 and beta 2 gene polymorphism and papillary thyroid cancer. Eun YG; Kim SK; Chung JH; Kwon KH Am J Surg; 2013 Jun; 205(6):631-5. PubMed ID: 23388428 [TBL] [Abstract][Full Text] [Related]
14. Missense polymorphisms in XIAP-associated factor-1 (XAF1) and risk of papillary thyroid cancer: correlation with clinicopathological features. Kim SK; Park HJ; Seok H; Jeon HS; Kim JW; Chung JH; Kwon KH; Woo SH; Lee BW; Baik HH Anticancer Res; 2013 May; 33(5):2205-10. PubMed ID: 23645777 [TBL] [Abstract][Full Text] [Related]
15. Association of CFTR gene polymorphisms with papillary thyroid cancer. Oh IH; Oh C; Yoon TY; Choi JM; Kim SK; Park HJ; Eun YG; Chung DH; Kwon KH; Choe BK Oncol Lett; 2012 Feb; 3(2):455-461. PubMed ID: 22740931 [TBL] [Abstract][Full Text] [Related]
16. Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer. Yuan Q; Bu Q; Li G; Zhang J; Cui T; Zhu R; Mu D Clin Endocrinol (Oxf); 2016 Apr; 84(4):564-70. PubMed ID: 26052935 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 beta polymorphisms are associated with lymph node metastasis in Korean patients with papillary thyroid carcinoma. Ban JY; Kim MK; Park SW; Kwon KH Immunol Invest; 2012; 41(8):888-905. PubMed ID: 23215728 [TBL] [Abstract][Full Text] [Related]
18. Association between interleukin 17/interleukin 17 receptor gene polymorphisms and papillary thyroid cancer in Korean population. Lee YC; Chung JH; Kim SK; Rhee SY; Chon S; Oh SJ; Hong IK; Eun YG Cytokine; 2015 Feb; 71(2):283-8. PubMed ID: 25484349 [TBL] [Abstract][Full Text] [Related]
19. FosB recruits KAT5 to potentiate the growth and metastasis of papillary thyroid cancer in a DPP4-dependent manner. Du J; Fu L; Ji F; Wang C; Liu S; Qiu X Life Sci; 2020 Oct; 259():118374. PubMed ID: 32891613 [TBL] [Abstract][Full Text] [Related]
20. The endothelin 1 and endothelin receptor A gene polymorphisms increase the risk of developing papillary thyroid cancer. Aydin AF; Vural P; Doğru-Abbasoğlu S; Çil E Mol Biol Rep; 2019 Feb; 46(1):199-205. PubMed ID: 30411193 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]